Navigation Links
Press statement on new CDC MMWR on Klebseilla pneumonia Carbapenemase-producing organisms
Date:3/18/2009

The Centers for Disease Control and Prevention (CDC) today released new infection control recommendations on Klebseilla pneumoniae Carbapenemase (KPC)-Producing Organisms, one of the most treatment-resistant gram-negative bacterium. Recent studies have shown that infections with these highly resistant bacteria are a growing problem in health care settings. In Guidance for Control of Infections with Carbapenem-Resistant or Carbapenemase-Producing Enterobacteriaceae in Acute Care Facilities published in the MMWR, CDC recommends an aggressive infection control approach to limit the emergence of these organisms.

Below Are Quotes from Mark Rupp, MD, President of SHEA

"The new guidelines highlight the need to educate clinicians and public health professionals about the importance of screening for Klebsiella pneuomoniae Carbapenemase (KPC)-Producing Organisms. If hospitals follow the CDC guidelines to detect and identify Klebsiella and Carbapenemase, then we can potentially halt the transmission of a highly treatment-resistant Gram-negative organism and prevent a large scale public health problem.

While KPC is still rare and occurs only sporadically in most parts of the country, an aggressive infection control approach needs to be taken now. These new guidelines suggest that facilities start by checking microbioloigy results for the last six to twelve months. Facilities finding evidence of these organisms should conduct a focused risk assessment or examine high-risk wards including intensive care units to make sure there is no evidence of ongoing transmission. The strategy for testing uses a selection process to get rid of most other organisms and focuses on the ones that are likely to be treatment-resistant including Carbapenem resistant Klebsiella.

For example, Israel has had widespread public health problems with these organisms, yet has managed to contain them in a short time period by implementing targeted screening and prevention practices.

The focused screening is important because there is a need to be both proactive in preventing the spread of KPCs yet judicious and mindful of limited hospital resources."


'/>"/>

Contact: Sharon Reis
sreis@gymr.com
202-745-5103
Society for Healthcare Epidemiology of America
Source:Eurekalert

Related biology news :

1. Regulatory molecule for tumor formation or suppression identified by Singapore, US researchers
2. American Chemical Societys weekly PressPac -- March 11, 2009
3. New tracking tags are providing fish-eye views of ways to manage depressed fisheries
4. Is it really only our kidneys that control blood pressure?
5. Researchers take first look at the genetic dynamics of inbreeding depression
6. Study suggests salt might be natures antidepressant
7. Children seriously affected when a parent suffers from depression
8. Chantix side effects no worse with depression history
9. Suppressing cancer with a master control gene
10. Press statement on new CDC MRSA study from SHEA president
11. Molecule that suppresses immune response under study in type 1 diabetes
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:5/16/2017)... , May 16, 2017   Bridge Patient ... organizations, and MD EMR Systems , an ... partner for GE, have established a partnership to ... product and the GE Centricity™ products, including Centricity ... These new integrations will allow ...
(Date:4/17/2017)... Florida , April 17, 2017 NXT-ID, ... technology company, announces the filing of its 2016 Annual Report on ... and Exchange Commission. ... on Form 10-K is available in the Investor Relations section of ... as on the SEC,s website at http://www.sec.gov . ...
(Date:4/11/2017)... No two people are believed to ... York University Tandon School of Engineering and Michigan ... partial similarities between prints are common enough that ... and other electronic devices can be more vulnerable ... in the fact that fingerprint-based authentication systems feature ...
Breaking Biology News(10 mins):
(Date:9/18/2017)... Calif. (PRWEB) , ... September 18, 2017 , ... ... forest harvest residues to produce biochar, briquettes, and torrefied wood is the topic ... research project. , To characterize the potential economic viability of transportable biomass conversion ...
(Date:9/18/2017)... , a growing leader in Electronic Trial Master file solutions ... research organization, Multidisciplinary Association for Psychedelic Studies (MAPS). ... MAPS Public Benefit Corporation selects ... ... for the treatment of Posttraumatic Stress Disorder (PTSD). MAPS also reached ...
(Date:9/17/2017)... ... September 17, 2017 , ... GeneOne Life Science, ... Food and Drug Safety (KMFDS) for an Investigational New Drug application for a ... Syndrome coronavirus (MERS-CoV). The study in Korea represents the second clinical trial for ...
(Date:9/14/2017)... ... September 14, 2017 , ... ... Services, formally introduces its flexible scientist program (FSP)-- a flexible business approach ... The FSP, which combines SSCI’s extensive project-based analytical and solid-state chemistry services ...
Breaking Biology Technology: